dc.contributor.author | Ceylan, Cengizhan | |
dc.contributor.author | Karataş Koçberber, Emine | |
dc.contributor.author | Taner, Neda | |
dc.contributor.author | Berk, Barkın | |
dc.date.accessioned | 10.07.201910:49:13 | |
dc.date.accessioned | 2019-07-10T19:56:37Z | |
dc.date.available | 10.07.201910:49:13 | |
dc.date.available | 2019-07-10T19:56:37Z | |
dc.date.issued | 2016 | en_US |
dc.identifier.citation | Ceylan, C., Koçberber, E., Taner, N. ve Berk, B. (2016). The determine of possible drug interaction of clarithromycin. International Journal of Clinical Pharmacy içinde (1341-1341. ss.). | en_US |
dc.identifier.issn | 2210-7703 | |
dc.identifier.issn | 2210-7711 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12511/2768 | |
dc.description | WOS: 000384561800054 | en_US |
dc.description.abstract | Phenytoin is an antiepileptic drug which is eliminated by CYP2C9, CYP2C19 (less important: CYP2C18, CYP3A4) enzyme. Therapeutic concentration range is very important due to the narrow therapeutic drug levels. Targeted therapeutic concentration range is 10–20 mg/L (40–80 lmol/L) in blood serum for adults and children older than 3 months. Phenytoin has highly variable pharmacokinetics due to its complex of binding to Albumin (%90). It is difficult to determine the correct dosage of this drug because of significant dose related toxicity. It is also important for inpatient in intensive care unit. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Springer | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Pharmacology | en_US |
dc.subject | Pharmacy | en_US |
dc.subject | Clinical Pharmacy | en_US |
dc.title | The determine of possible drug interaction of clarithromycin | en_US |
dc.type | conferenceObject | en_US |
dc.relation.ispartof | International Journal of Clinical Pharmacy | en_US |
dc.department | İstanbul Medipol Üniversitesi, Eczacılık Fakültesi, Eczacılık Meslek Bilimleri Bölümü, Klinik Eczacılık Ana Bilim Dalı | en_US |
dc.authorid | 0000-0002-6141-8676 | en_US |
dc.authorid | 0000-0001-6047-2796 | en_US |
dc.identifier.volume | 38 | en_US |
dc.identifier.issue | 5 | en_US |
dc.identifier.startpage | 1341 | en_US |
dc.identifier.endpage | 1341 | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.identifier.wosquality | Q4 | en_US |